SCHEMBL4900726

SCHEMBL4900726

COC(=O)c1cc(S(=O)(=O)NCCc2coc(C3CCCCC3)n2)ccc1C

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.44
LMNA P02545 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
ATM Q13315 1/20 0.38
YAP1 P46937 1/20 0.38
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
ALDH1A1 P00352 2/20 0.37
KDM4E B2RXH2 1/20 0.37
HPGD P15428 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
HTT P42858 2/20 0.37
TDP1 Q9NUW8 2/20 0.37
USP2 O75604 1/20 0.37
TSHR P16473 2/20 0.36
PKM P14618 2/20 0.36
ALOX15 P16050 2/20 0.36
MAPK1 P28482 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4903003 0.92 LMNA (0.49) KMT2ALMNAL3MBTL1NPC1RAB9A
SCHEMBL4900736 0.78 TSHR (0.39) KMT2ALMNAATMYAP1NPC1
SCHEMBL4900708 0.76 PPARG (0.41) KMT2ALMNAALDH1A1KDM4EHPGD
SCHEMBL4906842 0.75 LMNA (0.45) KMT2ALMNAALDH1A1KDM4EHPGD
SCHEMBL4907392 0.74 TDP1 (0.47) KMT2ALMNAL3MBTL1ALDH1A1SMN1; SMN2
SCHEMBL4902463 0.73 MAPT (0.66) KMT2ALMNAALDH1A1KDM4EHPGD
SCHEMBL4904133 0.72 MAPT (0.69) LMNAALDH1A1KDM4EHPGDSMN1; SMN2
SCHEMBL4902571 0.72 MAPT (0.69) LMNAALDH1A1KDM4EHPGDSMN1; SMN2
SCHEMBL4909112 0.70 MAPT (0.57) KMT2ALMNAALDH1A1KDM4EHPGD
SCHEMBL4908317 0.70 MAPT (0.55) KMT2ALMNAALDH1A1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD KMT2A 3602/4885LMNA 317/4885L3MBTL1 1234/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD KMT2A 3530/4885LMNA 319/4885L3MBTL1 1246/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.